2023-047 - Laserfiche WebLink

Home Browse Search

Numerator compliant: HbAlc performed and <8% in measurement period. Numerator noncompliant: if Hbalc > 8%, missing a result or not done in measurement period A nephropathy screening or monitoring test (Urine Protein); evidence of treatment for All patients 18- 75 with DM Type ?54% 1 or Type 2 nephropathy or ACE/ARB therapy; Evidence of stage 4 chronic kidney disease; evidence All patients 18 of ESRD; Evidence of kidney transplant; A 75 with Type ?86% visit with a nephrologist (as evidence by 1 or Typee 2 2 referral); At least 1 ACE inhibitor or ARB dispensing event ?51% Patients 18 and older screened for BMI All patients 18 years or older Patients 18-59 years of age whose BP was with a confirmed <140/90 mmHg; Patients 60-85 years of age dx of HTN w/ dx of DM whose BP was <140/90; documented in Patients 60-85 years of age w/o a dx of DM Problem list, OV whose BP was <150/90mmHg note, SOAP note, Patients 18 and older identified as current Encounter form, or heavy nicotine/tobacco users who dx report. ?51% Patients 18 and older screened for BMI All patients who are 18 years and >_60% using height and weight. older Patients 18 and older screened for clinical All patients who depression using either a PHQ-2 or PHQ-9 are 18 years and >_75% during the measurement period. older All patients who Patients 18 and older identified as current are 18 years and or heavy nicotine/tobacco users who older who receive evidence -based counseling focused identify as >_20% on shifting someone towards quitting current or heavy tobacco/nicotine use. tobacco or nicotine user a 2022 Bcrsidc Ilealth. I I.C. All ioeinetl. Cnnlidcntial 5% 5% 5% 5% 41